medigraphic.com
ISSN 1025-0255 (Electronic)

2020, Number 1

<< Back Next >>

AMC 2020; 24 (1)

New recommendations for the diagnosis and treatment of Helicobacter pylori infection in children

Aguilera-Matos I, Díaz-Oliva SE, García-Bacallao EF, Velazco-Villaurrutia YC, Mesa-Fajardo A

Language: Spanish
References: 52
Page: 126-143
PDF size: 1159.12 Kb.


ABSTRACT

Background: helicobacter pylori is one of the most prevalent bacteria in the world. In the pediatric population, the prevalence varies from 10 to 80 %. In recent years, the effectiveness of treatment schemes has been compromised and a complex scenario has been drawn up for the implementation of eradication treatments.
Objective: to deepen and update the most important aspects of helicobacter pylori infection in children.
Methods: the search for the information was made over a period of four months (November 2018 to March 2019) and the words: Helicobacter pylori in children, diagnostic methods, current treatments, coccoides were used. Of 138 articles in the PubMed, Hinari, SciELO and LILACS databases through the EndNote search manager and reference manager, 53 citations were used to perform the review, of which 40 were from the last five years, four meta-analysis studies and four multicenter studies.
Results: epidemiological and clinical characteristics, the advantages and disadvantages of the different diagnostic methods and based on the revision of this topic are proposed, modifications are proposed in the treatment schemes taking into account variables dependent on the bacteria and the individual.
Conclusions: this review provides an update of the infection in children, as well as updated treatment schedules.


REFERENCES

  1. Andrade Ruiseco M, García Pérez W, Davas Andrade Y, Hernández Reyes L. Importancia de Helico-bacter pylori en Pediatría, estudio diagnóstico en un grupo de niños. Rev Cubana Pediat [Internet]. 2017 [citado 10 Nov 2019];89(3):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034- 75312017000300003&lng=es&nrm=iso&tlng=es

  2. Fragoso Arbelo T, Rivas Domingo D, Trujillo Toledo ME, Cárdenas Bruno M, Revilla Machado F, Mi-lán Pavón R. Caracterización de la infección por Helicobacter pylori en niños y adolescentes en un ser-vicio ambulatorio. Rev Cubana Pediat [Internet]. 2018 [citado 10 Nov 2019];90(3):[aprox. 10 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312018000300005&lng=es&tlng=es

  3. Oderda G, Dicietti M, Pellicano R. Diagnosis and treatment of Helicobacter pylori infection in pediat-rics: recommendation for 2014 clinical practice. Minerva Pediatr [Internet]. 2015 Dec [citado 10 Nov 2019];67(6):[aprox. 8 p.]. Disponible en: https://europepmc.org/abstract/med/26530493

  4. Duquesne Alderete A, Llanes Caballero R, Feliciano Sarmiento O, Falcón Márquez R. Diagnóstico serológico de Helicobacter pylori en pacientes con síntomas digestivos. Rev Cubana Inv Bioméd [Internet]. 2017 [citado 21 Dic 2019];36(4):[aprox. 12 p.]. Disponible en: http://www.revibiomedica.sld.cu/index.php/ibi/article/view/64

  5. 5.Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut [Internet]. 2017 [citado 21 Dic 2019];66(1):[aprox. 24 p.]. Disponible en: https://gut.bmj.com/content/66/1/6?utm source=trendmd&utm_medium=cpc&utm_campaign=alljjs&utm_content=consumer&utm_term=1-A

  6. Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu M, et al. Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology [Internet]. 2016 [citado 21 Dic 2019];150(5): [aprox. 11 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0016508515001584

  7. Pellicano R. The appropriate age to study the incidence of Helicobacter pylori infection. Rev chilena pediat [Internet]. 2016 [citado 21 Dic 2019];87(6):[aprox. 1 p.]. Disponible en: https://scielo.conicyt.cl/pdf/rcp/v87n6/art17.pdf

  8. da Silva-Etto JMK, Mattar R, Villares Lopes CA, Dicques SB, Carrilho FJ. Evaluation of diagnostic accuracy of two rapid stool antigen tests using an immune chromatographic assay to detect Helico-bacter pylori. Clin Biochem [Internet]. 2017 [citado 21 Dic 2019];50(16-17):[aprox. 4 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/hel.12515

  9. Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of Helicobacter pylori in children and adolescents (Update 2016). J Pediat Gastroenterol Nutr [Internet]. 2017 [citado 21 Dic 2019];64(6):[aprox. 12 p.]. Dis-ponible en: https://journals.lww.com/jpgn/Fulltext/2017/06000/Joint_ESPGHAN_NASPGHAN_Guidelines_for_the.33.aspx

  10. Rojas MAB, Escobar AJG. Helicobacter Pylori: Vías de transmisión. Medicina [Internet]. 2017 [citado 21 Dic 2019];39(3):[aprox. 10 p.]. Disponible en: http://revistamedicina.net/ojsanm/index.php/Medicina/article/view/118-4/1482

  11. McMahon B, Bruce M, Koch A, Goodman K, Tsukanov V, Mulvad G, et al. The diagnosis and treat-ment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Com-mentary. Epidemiol Infect [Internet]. 2016 [citado 23 Dic 2019];144(2):[aprox. 8 p.]. Disponible en: https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0950268815001181

  12. Sugano K, Tack J, Kuipers EJ, Graham DY, El-ODic EM, Miura S, et al. Kyoto global consensus re-port on Helicobacter pylori gastritis. Gut [Internet]. 2015 [citado 23 Dic 2019];64(9):[aprox. 14 p.].Disponible en: https://gut.bmj.com/content/64/9/1353.short

  13. Castillo Montoya V, Ruiz Bustos E, Valencia Juillerat ME, Álvarez Hernández G, Sotelo Cruz N. De-tección de Helicobacter pylori en niños y adolescentes mediante coproantígeno monoclonal y su aso-ciación con gastropatías. Cirug Ciruj [Internet]. 2017 [citado 23 Dic 2019];85(1):[aprox. 7 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0009741116300421

  14. Torres Jiménez F, Torres Bayona C. Fisiopatología molecular en la infección por Helicobacter pylori. Rev Salud Uninorte [Internet]. 2016 [citado 23 Dic 2019];32:[aprox. 12 p.]. Disponible en: https://www.redalyc.org/pdf/817/81750089012.pdf

  15. Verne Ugarte CA, Bullard Elías D, Espino V, Fiorella A. Prevalencia de Helicobacter pylori en pobla-ción pediátrica menor de 15 años determinada mediante biopsias gástricas, en el Hospital Cayetano Heredia entre Dicro 2007 a Julio del 2016 [Tesis]. Peru:Universidad Peruana Cayetano Heredia;2017 [citado 23 Dic 2019]. Disponible en: http://repositorio.upch.edu.pe/bitstream/handle/upch/627/Prevalencia+de+Helicobacter+pylori+en+poblaci%C3%B3n+pedi%C3%A1trica+menor+de+15+a%C3%B1os+determinada+mediante+biopsias+g%C3%A1stricas, +en+el+Hospital+Cayetano+Heredia+entre+Dicro+2007+a+julio+del+2016.pdf?sequence=1

  16. Megraud F, Floch P, Labenz J, Lehours P. Diagnostic of Helicobacter pylori infection. Helicobacter [Internet]. 2016 [citado 23 Dic 2019];21(Suppl 1):[aprox. 6 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/hel.12333

  17. Thung I, Aramin H, Vavinskaya V, Gupta S, Park J, Crowe S, et al. The global emergence of Heli-cobacter pylori antibiotic resistance. Aliment Pharmacol Ther [Internet]. 2016 [citado 23 Dic 2019];43(4):[aprox. 19 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/apt.13497

  18. Adu-Aryee NA, Aabakken L, Dedey F, Nsaful J, Kudzi W. Comparison of endoscopic based diagno-sis with Helicobacter urease test for Helicobacter pylori infection. BMC Res Notes [Internet]. 2016 [citado 23 Dic 2019];9(1):[aprox. 6 p.]. Disponible en: https://bmcresnotes.biomedcentral.com/articles/10.1186/s13104-016-2237-6

  19. Shehata MA, Talaat R, Soliman S, Elmesseri H, Soliman S, Abd‐Elsalam S. Randomized controlled study of a novel triple nitazoxanide (ntz)‐containing therapeutic regimen versus the traditional regi-men for eradication of helicobacter pylori infection. Helicobacter [Internet]. 2017 [citado 23 Dic 2019];22(5):[aprox. 2 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/hel.12395

  20. Sarem M, Corti R. Rol de las formas cocoides de Helicobacter pylori en la infección y la recrudes-cencia. Gastroent Hepat [Internet]. 2016 [citado 23 Dic 2019]; 39(1): [aprox. 7 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210570515001120

  21. Sugizaki K, Tari A, Kitadai Y, Oda I, Nakamura S, Yoshino T, et al. Anti‐Helicobacter pylori therapy in localized gastric mucosa‐associated lymphoid tissue lymphoma: A prospective, nationwide, multi-center study in Japan. Helicobacter [Internet]. 2018 [citado 23 Dic 2019];23(2):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900897/pdf/HEL-23-na.pdf

  22. Otero W. Helicobacter pylori en agua potable ¿Es la ruta de la infección? Acta Med Colomb [Internet]. 2017 [citado 23 Dic 2019];42(2):[aprox. 3 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-24482017000200087&lng=en

  23. Olivier BJ, Bond RP, Van Zyl WB, Delport M, Slavik T, Ziady C, et al. Absence of Helicobacter pylori within the oral cavities of members of a healthy South African community. J Clin Microbiol [Internet]. 2006 [citado 23 Dic 2019];44(2):[aprox. 2 p.]. Disponible en: https://jcm.asm.org/content/44/2/635.short

  24. Dowsett SA, Kowolik MJ. Oral Helicobacter pylori: Can we stomach it? Critical Reviews in Oral Biol-ogy&Medicine [Internet]. 2003 [citado 23 Dic 2019];14(3):[aprox. 8 p.]. Disponible en: https://journals.sagepub.com/doi/abs/10.1177/154411130301400307

  25. Tsami A, Petropoulou P, Kafritsa Y, Mentis Y, Roma E. The presence of Helicobacter pylori in dental plaque of children and their parents: is it related to their periodontal status and oral hygiDic? Eur J Paediatr Dent [Internet]. 2011 Dec [citado 23 Dic 2019];12(4):[aprox. 6 p.]. Disponible en: https://europepmc.org/abstract/med/22185245

  26. Siavoshi F, Taghikhani A, Malekzadeh R, Sarrafnejad A, Kashanian M, Jamal AS, et al. The role of mother's oral and vaginal yeasts in transmission of Helicobacter pylori to neonates. Arch Iran Med [Internet]. 2013 May [citado 23 Dic 2019];16(5):[aprox. 8 p.]. Disponible en: https://www.researchgate.net/profile/Reza_Malekzadeh/publication/236635861_The_Role_of_Mother%27s_Oral_and_Vaginal_Yeasts_in_Transmission_of_Helicobacter_Pylori_to_Neonates/links/00b495378fe9dccb4f000000/The-Role-of-Mothers-Oral-and-Vaginal-Yeasts-in-Transmission-of-Helicobacter-Pylori-to-Neonates.pdf

  27. Gomes B, De Dictinis E. Fate of Helicobacter pylori artificially inoculated in lettuce and carrot sam-ples. Braz J Microbiol [Internet]. 2004 [citado 23 Dic 2019];35:[aprox. 6 p.]. Disponible en: http://www.scielo.br/scielo.php?pid=S1517-8382200400 010 00 24 &s cri pt=sci_arttext&tlng=pt

  28. Buck A, Oliver J. Survival of spinach-associated Helicobacter pylori in the viable but nonculturable state. Food Control [Internet]. 2010 [citado 23 Dic 2019];21:[aprox. 5 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S095671351000037X

  29. Liu J, Li L, Peters BM, Li B, Chen L, Deng Y, et al. The viable but nonculturable state induction and genomic analyses of Lactobacillus casei BM‐LC14617, a beer‐spoilage bacterium. Microbiol Open [Internet]. 2017 [citado 23 Dic 2019];6(5):[aprox. 8 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1002/mbo3.506

  30. De Falco M, Lucariello A, Iaquito S, Esposito V, Guerra G, De Luca A. Molecular mechanisms of He-licobacter pylori patogénesis. J Cell Physiol [Internet]. 2015 [citado 23 Dic 2019];29:[aprox. 6 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-55522016000300013

  31. Yokota S, Ohnishi T, Muroi M, Tanamoto K, Fujii N, Amano K. Highly-purified Helicobacter pylori LPS preparations induce weak inflammatory reactions and utilize Toll-like receptor 2 complex but not Toll-like receptor 4 complex. FEMS Immunol Med Microbiol [Internet]. 2007 [citado 23 Dic 2019];51:[aprox. 9 p.]. Disponible en: https://academic.oup.com/femspd/article/51/1/140/500488

  32. Feliciano O, Gutiérrez O, Valdés L, Fragoso T, Calderín A, Valdés A, et al. Prevalence of Helicobac-ter pylori vacA, cagA, and iceA Genotypes in Cuban Patients with Upper Gastrointestinal Diseases. Bi-oMed Res Int [Internet]. 2015 [citado 23 Dic 2019];2015:[aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402555/.

  33. Tan B, Yang JC, Young CL, Bishu S, Owyang SY, El Zaatari M, et al. Helicobacter pylori Antimicro-bial Susceptibility Testing Guided Salvage Therapy in the USA: A Real Life Experience. Dig Dis Sci [Internet]. 2018 [citado 23 Dic 2019];63(2):[aprox. 8 p.]. Disponible en: https://link.springer.com/article/10.1007/s10620-017-4880-8

  34. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic re-sistance. Gut [Internet]. 2010 [citado 23 Dic 2019];59(8):[aprox. 10 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/20525969

  35. Thankachan P, Muthayya S, Sierksma A, Eilander A, Thomas T, Duchateau GS, et al. Helicobacter pylori infection does not influence the efficacy of iron and vitamin B(12) fortification in Dicginally nourished Indian children. Eur J Clin Nutr [Internet]. 2010 [citado 23 Dic 2019];64:[aprox. 7 p.]. Dis-ponible en: https://www.nature.com/articles/ejcn2010126

  36. Brito HS, Braga JA, Loggetto SR, Machado RS, Granato CF, Kawakami E, et al. Helicobacter pylori infection and immune thrombocytopenic purpura in children and adolescents: a randomized controlled trial. Platelets [Internet]. 2015 [citado 23 Dic 2019];26(4):[aprox. 6 p.]. Disponible en: https://www.tandfonline.com/doi/abs/10.3109/09537104.2014.911836

  37. Khakoo S, Lobo A, Shepherd N, Wilkinson S. Histological assessment of the Sydney classification of endoscopic gastritis. Gut [Internet]. 1994 [citado 23 Dic 2019];35(9):[aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/7959220

  38. Crowley E, Bourke B, Hussey S. How to use Helicobacter pylori testing in paediatric practice. Arch Dis Child Educ Pract Ed [Internet]. 2013 [citado 23 Dic 2019];98:[aprox. 7 p.]. Disponible en: https://ep.bmj.com/content/98/1/18?utm_source=trendmd&utm_ medium=cpc&utm_campaign=adcep&utm_content=consumer&utm_term=0-A

  39. Gisbert JP, Molina Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, et al. IV Spanish Consen-sus Conference on Helicobacter pylori infection treatment. Gastroenterol Hepatol [Internet]. 2016 [citado 12 Dic 2019];39:[aprox. 24 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0210570516300589

  40. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto Consen-sus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterol [Internet]. 2016 [citado 12 Dic 2019];151:[aprox. 18 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0016508516301081

  41. Kagami T, Sahara S, Ichikawa H, Uotani T, Yamade M, Sugimoto M, et al. Potent acid inhibition by vonoprazan in comparison with esomeprazole, with referenceto CYP2C19 genotype. Aliment Pharma-col Ther [Internet]. 2016 [citado 12 Dic 2019];43(10):[aprox. 12 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/full/10.1111/apt.13588

  42. Molina Infante J, Corti R, Doweck J, McNicholl AG, Gisbert JP. Avances recientes en el tratamiento de la infección por Helicobacter pylori. Acta Gastroenterol Latinoam [Internet]. 2017 [citado 12 Dic 2019];47(1):[aprox. 5 p.]. Disponible en: https://www.redalyc.org/html/1993/199350528013/.

  43. Yuan Y, Ford AC, Khan KJ, Gisbert JP, Forman D, Leontiadis GI, et al. Optimum duration of regi-mens for Helicobacter pylori eradication. Cochrane Database Syst Rev [Internet]. 2013 [citado 12 Dic 2019];(12):[aprox. 5 p.]. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008337.pub2/full

  44. Graham DY, Lee YC, Wu MS. Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence. Clin Gastroenterol Hepatol [Internet]. 2014 [citado 12 Dic 2019];12(2):[aprox. 9 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S1542356513007738

  45. Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, et al. The Toronto consen-sus for the treatment of Helicobacter pylori infection in adults. Gastroenterology [Internet]. 2016 [citado 12 Dic 2019];151(1):[aprox. 18 p.]. Disponible en: https://www.sciencedirect.com/science/article/pii/S0016508516301081

  46. Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, et al. Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut [Internet]. 2013 [citado 12 Dic 2019];62:[aprox. 8 p.]. Disponible en: https://gut.bmj.com/content/62/1/34.short

  47. Guzmán Guerrero K. Determinación de la resistencia a la claritromicina como fármaco de primera línea, en aislamientos de Helicobacter pylori provenientes de biopsias gástricas del Hospital Eugenio Espejo y Hospital de las Fuerzas Armadas N° 1, mediante técnicas fenotípica (E-test), molecular (Reacción en cadena de la polimerasa, PCR) y secuenciación genómica, durante el período julio-diciembre 2015 [Tesis]. Ecuador: Pontificia Universidad Católica del Ecuador; 2016 [citado 12 Dic 2019]. Disponible en: http://repositorio.puce.edu.ec/bitstream/handle/22000/12526/TESIS%20H.%20pylori%20GUZMAN%20K..pdf?sequence=1&isAllowed=y

  48. Muñoz Gómez P, Jordán Castro JA, Abanades Tercero M, Blanco González JJ, Andrés Esteban EM, Valle Muñoz J. Macrolide use in the previous years is associated with failure to eradicate helicobacter pylori with clarithromycin‐containing regimens. Helicobacter [Internet]. 2018 [citado 12 Dic 2019];23(1):[aprox. 6 p.]. Disponible en: https://onlinelibrary.wiley.com/doi/abs/10.1111/hel.12452

  49. Llanes Caballero R, Sarmiento OF, González OG, González ÁG, Alonso l. Nuevos conocimientos sobre el diagnóstico y la resistencia antimicrobiana de helicobacter pylori en cuba. Rev Anal Acad Cien Cuba [Internet]. 2014 [citado 12 Dic 2019];4(2):[aprox. 4 p.]. Disponible en: http://www.revistaccuba.cu/index.php/revacc/article/view/192

  50. Nayar DS. Current eradication rate of Helicobacter pylori with clarithromycin-based triple therapy in a gastroenterology practice in the New York metropolitan area. Infect Drug Res [Internet]. 2018 [citado 12 Dic 2019];11:[aprox. 5 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797467/.

  51. Boltin D, Ben-Zvi H, Perets TT, Kam Dictsky Z, Samra Z, Dickman R, et al. Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned? J Clin Microbiol [Internet]. 2015 [citado 12 Dic 2019];53(2):[aprox. 6 p.]. Disponible en: https://jcm.asm.org/content/53/2/522.short

  52. Shiota S, Reddy R, Alsarraj A, El-Serag HB, Graham DY. Antibiotic resistance of Helicobacter pylo-ri among male United States veterans. Clin Gastroenterol Hepatol [Internet]. 2015 [citado 12 Dic 2019];13(9):[aprox. 8 p.]. Disponible en: https://jcm.asm.org/content/53/2/522.short




2020     |     www.medigraphic.com